Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation

Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation GlobeNewswire October 30, 2025 LA PALMA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — Liminatus Pharma, Inc. (NASDAQ: LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it […]

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in James Hardie Industries plc of Class Action Lawsuit and Upcoming Deadlines – JHX

(NYSE:JHX), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in James Hardie Industries plc of Class Action Lawsuit and Upcoming Deadlines – JHX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in James Hardie Industries plc of Class Action Lawsuit and Upcoming Deadlines – JHX GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (“James

Doceree Recognized by OpenAI for Crossing 10 Billion Tokens, Reinforcing its Leadership in AI-Driven Healthcare Marketing

Doceree, the world's only AI-powered Operating System for healthcare marketing, has been recognized by OpenAI for surpassing the 10 billion-token milestone – a recognition reserved for the world's most advanced users of AI technology. https://mma.prnewswire.com/media/2809411/Doceree_OpenAI.jpg This milestone underscores Doceree's pioneering role in transforming how life-sciences brands engage with healthcare professionals through intelligent, data-driven communication. By

Grant Thornton Stax Appoints Chen Liu as Partner to Drive Growth in Technology and Education Sectors

Stax, part of the Grant Thornton Advisors LLC multinational platform, and a global strategy consulting firm specializing in commercial due diligence, value creation, and exit planning for private equity firms, PE-backed companies, hedge funds, and investment banks, today announced the appointment of Chen Liuas Partner in its Chicago office. https://mma.prnewswire.com/media/2802880/Grant_Thornton_Stax_Chen_Liu.jpg With more than a decade

Loudoun Roofing, Recognized as a Leading Roof Replacement Contractor in Leesburg, VA, Announces a Limited-Time Fall Promotion

Leesburg, VA – Loudoun Roofing, a leading residential roofing contractor based in Leesburg, Virginia, continues to earn recognition as one of the most trusted names in roof replacement across Loudoun County. Serving the area since 1984, the company has built a reputation for delivering high-quality craftsmanship, dependable service, and long-term value for homeowners. This fall,

MD&M Midwest 2025 Celebrates 30 Years of Medtech Innovation as Industry Leaders Converge in Minneapolis

Minneapolis Convention Center Hosted Midwest’s Design and Manufacturing Event October 21-22, 2025 MINNEAPOLIS, MN / ACCESS Newswire / October 30, 2025 / MD&M Midwest 2025 successfully concluded last week, reinforcing its position as the Midwest’s largest annual end-to-end design and manufacturing event. The milestone 30 th anniversary celebration attracted record attendance as the two-day conference

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK

(NASDAQ:CYTK), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate (“Cytokinetics” or the “Company”) (NASDAQ: CYTK).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in VF Corporation of Class Action Lawsuit and Upcoming Deadlines – VFC

(NYSE:VFC), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation (“VFC” or the “Company”) (NYSE: VFC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Cytokinetics, Incorporate of Class Action Lawsuit and Upcoming Deadlines – CYTK GlobeNewswire October 30, 2025 NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Cytokinetics, Incorporate (“Cytokinetics” or the “Company”) (NASDAQ:

Scroll to Top